Table 2. Evaluation of the tumors using HRCT and 3D CT in each group.
Variables | Total (n=195) | HL group (n=57) | TL group (n=138) | P value |
---|---|---|---|---|
Clinical T status, n (%) | 0.033 | |||
Tis | 19 [10] | 0 [0] | 19 [14] | |
T1mi | 40 [21] | 16 [28] | 24 [17] | |
T1a-T1c | 136 [69] | 41 [72] | 95 [69] | |
HRCT findings | ||||
Whole tumor size (cm) | 0.579 | |||
Range | 0.5–4.4 | 0.6–4.1 | 0.5–3.9 | |
Mean ± SD | 1.93±0.76 | 1.97±0.74 | 1.92±0.76 | |
Solid tumor size (cm) | 0.045 | |||
Range | 0–3.0 | 0.3–2.6 | 0–3.0 | |
Mean ± SD | 1.08±0.78 | 1.11±0.78 | 1.07±0.78 | |
3D CT findings | ||||
Whole tumor volume (mm3) | 0.466 | |||
Range | 102.0–22,876.5 | 214.1–1,8981.2 | 102.0–2,2876.5 | |
Mean ± SD | 2,975.0±3,426.7 | 2,994.8±3,450.0 | 2,966.8±3,426.7 | |
Solid tumor volume (mm3) | 0.329 | |||
Range | 0–7,044 | 0.5–4,839.1 | 0–7,044 | |
Mean ± SD | 1,026.0±1,364.5 | 779.3±1,358.0 | 1,127.9±1,361.3 |
HRCT, High-resolution computed tomography; 3D CT, three-dimensional computed tomography; SD, standard deviation; HL, Hazy lesion; TL, typical lesion.